Choate Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426K Hold
4,438
0.01% 344
2026
Q1
$484K Sell
4,438
-344
-7% -$32.8K 0.01% 303
2025
Q4
$388K Sell
4,782
-1,050
-18% -$90.4K 0.01% 341
2025
Q3
$510K Hold
5,832
0.01% 281
2025
Q2
$484K Hold
5,832
0.01% 277
2025
Q1
$489K Hold
5,832
0.01% 260
2024
Q4
$537K Hold
5,832
0.01% 262
2024
Q3
$542K Hold
5,832
0.01% 258
2024
Q2
$480K Hold
5,832
0.01% 256
2024
Q1
$387K Hold
5,832
0.01% 298
2023
Q4
$331K Hold
5,832
0.01% 296
2023
Q3
$318K Sell
5,832
-795
-12% -$47.1K 0.01% 287
2023
Q2
$446K Hold
6,627
0.02% 213
2023
Q1
$341K Hold
6,627
0.02% 214
2022
Q4
$305K Hold
6,627
0.02% 223
2022
Q3
$336K Hold
6,627
0.02% 195
2022
Q2
$302K Buy
+6,627
New +$296K 0.02% 215

Other funds holding LMAT

Choate Investment Advisors's LMAT Position: Q2 2026 in Review

Choate Investment Advisors held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 4,438 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #344.

Choate Investment Advisors first reported a position in LMAT in Q2 2022 and has held it in 17 quarters since. The position peaked at $542K in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Choate Investment Advisors held 4,438 shares of LeMaitre Vascular worth $426K as of Q2 2026.
  • Choate Investment Advisors left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up 0.01% of Choate Investment Advisors's portfolio in Q2 2026, its #344 holding.
  • Choate Investment Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 17 quarters since.
  • Choate Investment Advisors's LeMaitre Vascular position peaked at $542K in Q3 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Choate Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.